Press Releases July 30, 2026 08:00 AM

PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026

PetMed Express to announce Q1 FY2027 financial results on August 13, 2026, followed by a conference call and webcast.

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
PETS

PetMed Express, a leading online pet pharmacy, will release its financial results for the first quarter ended June 30, 2026, on August 13, 2026. The company will hold a conference call and webcast to discuss the results. PetMed Express operates nationally and offers a wide range of pet healthcare products through its PetMeds and PetCareRx brands.

PetMed Express, Inc. to Report First Quarter Fiscal Year 2027 Financial Results on Thursday, August 13, 2026
PETS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • PetMed Express will report Q1 FY2027 financial results on August 13, 2026 after market close.
  • A conference call and webcast are scheduled for the same day to discuss the results.
  • The company is a pioneer in direct-to-consumer pet healthcare, offering pharmaceuticals and supplements nationwide through online platforms.

DELRAY BEACH, Fla., July 30, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) today announced it will report financial results for the first quarter fiscal year ended June 30, 2026, on Thursday, August 13, 2026 after market close. The Company will host a conference call and webcast to review these results at 4:30pm Eastern Time on the same day.

Date: Thursday, August 13, 2026
Time: 4:30pm Eastern Time (1:30pm Pacific Time)
U.S. dial-in number: 877-407-0789
International number: 201-689-8562
Webcast: 1Q Earnings Webcast

A telephonic replay of the conference call will also be available after 7:30 PM Eastern Time on the same day through August 27, 2026.

Toll-free replay number: 844-512-2921
International replay number: 412-317-6671
Replay passcode: 13761872

About PetMed Express, Inc.

Founded in 1996, PetMeds is a pioneer in the direct-to-consumer pet healthcare sector. As a trusted national online pharmacy, PetMeds is licensed across all 50 states and staffed with expert pharmacists dedicated to supporting pet wellness, pets and pet parents, and the veterinarians who serve them. Through its PetMeds family of brands and through its PetCareRx subsidiary, the Company offers a comprehensive range of pet health solutions - including top-brand and generic pharmaceuticals, compounded medications, and better-for-your-pet OTC supplements and nutrition. Focused on value, convenience, and care, PetMeds and PetCareRx empower pet parents to help their dogs, cats, and horses live longer, healthier lives. To learn more, visit www.PetMeds.com and www.PetCareRx.com.

Investor Contact:
ICR, LLC
Reed Anderson
(646) 277-1260
[email protected]


Risks

  • Financial performance might not meet market expectations, impacting stock price.
  • Market competition in the online pet healthcare sector may affect growth prospects.
  • Regulatory changes impacting online pharmaceutical sales or pet healthcare could increase operational risks.

More from Press Releases

Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel Jul 30, 2026 How CNH precision technology is helping family farms turn data into better decisions Jul 30, 2026 Decent Holding Advances AI-Powered Health Data Infrastructure Alongside Community Healthcare Network Expansion Jul 30, 2026 United Maritime Reports Second Quarter and First Half 2026 Financial Results Jul 30, 2026 L.B. Foster Company Announces Executive Officer Changes Jul 30, 2026